ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,148,343 | +18.8% | 1,171,779 | +68.5% | 0.34% | +26.3% |
| Q2 2023 | $966,470 | +324.0% | 695,302 | +385.0% | 0.27% | +285.7% |
| Q1 2023 | $227,946 | -92.2% | 143,362 | -69.5% | 0.07% | -92.1% |
| Q4 2022 | $2,928,723 | +68.1% | 470,100 | +80.8% | 0.88% | +32.3% |
| Q3 2022 | $1,742,000 | +58.8% | 260,000 | +50.7% | 0.67% | +39.7% |
| Q2 2022 | $1,097,000 | -43.6% | 172,500 | -58.9% | 0.48% | -38.0% |
| Q1 2022 | $1,945,000 | -22.2% | 419,262 | -16.1% | 0.77% | +24.0% |
| Q4 2021 | $2,500,000 | – | 500,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |